A new article on the Health Affairs website argues:
The federal government should raise the user fees paid by
drug companies to the Food and Drug Administration (FDA) to help
finance safety studies once a drug has hit the market, according to a
new article published today on the Health Affairs Web site.
It’s left to those outside of academia to argue against the FDA’s even more dangerous delay of getting drugs to the market in the first place.
